A Study to Assess Whether Macitentan Delays Disease Progression in Children With Pulmonary Arterial Hypertension (PAH)
Status:
Recruiting
Trial end date:
2022-12-20
Target enrollment:
Participant gender:
Summary
This is a prospective, multicenter, open-label, randomized, controlled, parallel group,
group-sequential, event-driven Phase 3 study to evaluate efficacy, safety and
pharmacokinetics (PK) of macitentan in children.